Dipharma is a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients, with more than 500 employees, 4 cGMP plants and commercial offices in Italy, U.S.A. and China.

We put our heart and soul into supporting our customers with a competitive and highly proactive approach, backed by 75 years of experience in safely handling hazardous chemical processes using state-of-the-art technologies.

Dipharma is an organization with strong values of responsibility and integrity.

As a company with businesses and operations in several countries, we have a global responsibility to ensure proper conduct and, for that reason, we have decided to adopt a common Code of Ethics that contains the general guidelines for managing our business and that of our branches.

Dipharma is committed to ensuring good corporate governance because we believe that good corporate
governance benefits all stakeholders, whether they are customers, suppliers, employees, or shareholders.

The Board of Directors of Dipharma Francis S.r.l. is comprised of 4 members.
The Board of Directors is responsible for defining the strategic business guidelines
and monitoring operational management. The Board consists of non-executive
directors with industry expertise and specific technical skills.